MedTrace Logo

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

NCT01484028 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 275

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.

Conditions

  • Refractive Ametropia

Interventions

DEVICE

etafilcon A control lens (1DM)

A marketed daily disposable contact lens

DEVICE

etafilcon A with print and PVP for light eyes (EALE)

A daily disposable contact lens

DEVICE

etafilcon A with print and PVP for dark eyes (EADE)

A daily disposable contact lens

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
34 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01484028 on ClinicalTrials.gov